Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
For Researchers | Link your sites and fill your trials
Our website attracts 120,000 patients annually seeking information on treatments and clinical trials. We facilitate direct connections between these patients and trial organizers through our Clinical Trials page, which features verified study details.
However, we recognize that some participating sites face challenges in recruiting sufficient participants due to limited visibility. To address this, we offer a complimentary service to highlight these sites in our announcements, complete with direct contact information for each specific location. This additional exposure aims to boost recruitment efforts at no extra cost to researchers.
FAQOther Questions
- Awareness Days Similar to World Vitiligo Day
World Vitiligo Day, celebrated annually on June 25 since 2012, is a significant event dedicated to raising awareness about vitiligo and supporting those affected by the conditio...
- Isn't it just a cosmetic disorder?
Contrary to popular belief, vitiligo is not merely a cosmetic issue but a complex autoimmune disorder that affects the body’s largest organ—along with other vital systems—and is...
- Shall I try low-fat diet for my vitiligo?
The link between dietary fat and autoimmune diseases like vitiligo is a compelling yet complex puzzle that continues to intrigue scientists. While the conversation is ongoing, o...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.